Simple fiber supplements may reshape the gut microbiome, stabilize blood sugar spikes, and even prevent premature birth in high-risk pregnancies, providing a promising new avenue for precision prenatal care.
study: Dietary fiber supplementation reduces the risk of gestational diabetes and preterm birth through modulation of the gut microbiota: a randomized controlled trial. Image credit: dilyaz/Shutterstock.com
new research in Frontiers of endocrinology We evaluated the effectiveness of soluble dietary fiber supplementation in altering glucose metabolism and pregnancy outcome during pregnancy by modulating gut microbiota.
Gestational diabetes and fiber-mediated microbiome regulation during pregnancy
Gestational diabetes mellitus (GDM) is a type of high blood sugar (hyperglycemia) that develops during pregnancy, usually during the second or third trimester, and is caused by placental hormones that impair the action of insulin. The disease affects 7-10% of pregnancies worldwide, and the incidence is increasing in parallel with economic development and lifestyle changes.
Multiple studies have highlighted that GDM poses significant risks to the mother and newborn, including increased long-term susceptibility to gestational hypertension, preterm birth, macrosomia, and type 2 diabetes mellitus (T2DM). Therefore, it is important to develop targeted prevention strategies, especially in high-risk populations defined by maternal advanced age, obesity, or family history of diabetes.
The gut microbiota has emerged as an important regulator of host glucose homeostasis, and gut microbiota dysbiosis is increasingly associated with the pathophysiology of GDM. Affected individuals exhibit characteristic changes in the microbial composition, particularly an increased abundance of Corynebacteria and Bacteroidetes genera.
Dietary fibers containing indigestible plant polysaccharides have demonstrated protective effects against metabolic dysfunction. High fiber intake during pregnancy is associated with reduced gestational weight gain and fat storage, and poorer postpartum weight maintenance compared to low fiber controls.
Epidemiological data further indicate a significant inverse association between dietary fiber intake and T2DM risk. These benefits are mechanistically attributed to microbial fermentation of fiber into short-chain fatty acids (SCFAs), which reduce insulin resistance and systemic inflammation. Furthermore, selective enrichment of SCFA-producing taxa such as Prevotella and Bifidobacterium also contributes to the beneficial effects. Despite these established benefits, approximately 70% of pregnant women consume insufficient dietary fiber.
Evaluation of the effects of dietary fiber on intestinal microbiota and glucose metabolism during pregnancy
This single-center randomized controlled trial (RCT) investigated the effects of dietary fiber on GDM risk, glycemic control, and gut microbiota. Eligible participants were between 18 and 50 years of age with a singleton pregnancy, were 35 years of age or older, had pre-pregnancy BMI ≥25 kg/m2, had at least two GDM risk factors including family history of diabetes, history of GDM or polycystic ovary syndrome (PCOS), or history of macrosomia delivery, and were not using antibiotics or probiotics during pregnancy.
Women with pre-existing medical conditions such as hyperthyroidism, liver or pancreatic disease, cardiovascular disease, pregestational diabetes, or related drug use were excluded. Eligible women were stratified by age, GDM history, and BMI. They were then randomly assigned to either a control group, which received regular prenatal care, or a fiber group, which received two sachets of soluble fiber powder dissolved in warm water per day from 20 to 24+6 weeks of pregnancy.
Adherence was monitored through returned sachets and daily side effect records. Both groups received standardized nutrition education according to Chinese dietary guidelines for pregnant women. All participants underwent a 75g oral glucose tolerance test (OGTT) at weeks 25-28. GDM was diagnosed when one of the following thresholds was met: fasting plasma glucose (FPG) ≥ 5.1 mmol/L, 1-h plasma glucose (PG) ≥ 10.0 mmol/L, or 2-h PG ≥ 8.5 mmol/L.
Fiber intervention reduces postprandial blood glucose levels, gestational weight gain, and risk of preterm birth
A total of 98 pregnant women (control: 50, fiber group: 48) completed the study and were well matched at baseline, with no significant differences in age, BMI, parity, or metabolic parameters, ensuring reliable comparisons between groups.
Dietary fiber supplementation has been shown to be beneficial in regulating postprandial blood sugar levels. Women in the fiber group had significantly lower blood glucose levels after 1 hour and decreased area under the curve (AUC and iAUC) values, indicating a more controlled blood sugar response. However, fasting blood glucose, HbA1c, and insulin resistance (HOMA-IR) were not significantly different between groups, supporting that the benefit was primarily limited to postprandial blood glucose fluctuations.
Although the overall GDM diagnosis rate was not significantly different between groups (20.8% in the fiber group and 26.0% in the control group), the fiber group consistently showed better glycemic control during the OGTT.
Although both groups started at similar weights, the fiber group gained significantly less weight and had a smaller increase in BMI over the 5-week intervention period than the control group. This suggests that dietary fiber helped alleviate gestational weight gain during the third trimester, but this effect did not necessarily translate into lower total gestational weight gain due to the longer gestational age in the dietary fiber group.
No women in the fiber group experienced preterm birth, while the preterm birth rate in the control group was 12%. The fiber group also had a significantly higher mean gestational age at birth of 39.04 weeks compared to 38.33 weeks, suggesting a potential protective effect of fiber on gestational age.
Fiber supplementation led to meaningful changes in the composition of the gut microbiota. At the phylum level, after intervention, Bacteroidetes was most prevalent in the fiber group, and the abundance of Actinobacteria significantly increased. At the genus level, Bifidobacterium significantly increased in the fiber group, while Phascolactobacterium decreased.
These changes reflect a potentially more favorable microbiome profile for metabolic health, based on associations observed in previous studies, rather than evidence of direct causation in this trial. Interestingly, alpha diversity was reduced in the fiber group, which the authors interpret as a possible stabilization of microbial composition, but the reduction in diversity is not universally beneficial and its clinical significance remains unclear.
While in the control group, nine bacterial species were associated with glucose metabolism and four with body weight, there were fewer such associations in the fiber group, suggesting that fiber may have attenuated or altered, rather than definitively ‘normalized’, the typical relationships between specific microorganisms and glucose or body weight measurements, and may have reduced previously observed correlations between certain taxa (such as Bifidobacterium-related groups) and fasting blood glucose.
Functional analysis revealed Based on predictive functional profiling rather than direct metabolite measurements, the control group’s microbiota was enriched in 22 metabolic pathways associated with inflammation, whereas the fiber group showed enrichment in only one.indicating fewer predicted disruptions in metabolic and inflammatory pathways.
The combined clinical and microbiome model achieved the strongest GDM prediction performance, outperforming the clinical-only and microbiome-only models. However, this model was developed and internally validated in a small cohort and requires external validation before clinical use. The intervention was overall well-tolerated, with only mild side effects such as bloating, dizziness, diarrhea, and abdominal pain reported by 14.8% of participants in the fiber group, and only two discontinuations. Compliance was high, with 83.3% of completers taking 95% or more of the prescribed fiber powder, and the average intake rate was 96.6%.
conclusion
Dietary fiber supplementation in high-risk pregnancies has shown potential to support postprandial glucose homeostasis, limit excessive weight gain, and reduce the risk of preterm birth. These benefits appear to be mediated, at least in part, by modulation of key gut microbiomes, such as Bifidobacteria.
Combining microbiome characteristics with clinical indicators further enhances early GDM risk prediction. However, given the small single-center design, limited sample size, and reliance on predictive microbiome analysis without direct metabolite measurements, these findings should be considered preliminary. In the future, these findings should be validated using larger multicenter cohorts and advanced precision nutrition in prenatal care.
Click here to download your PDF copy.
